EIR Brochure Final 2 Paperturn - Flipbook - Page 14
VÉRONIQUE BOUCHET
Chief Medical Officer
Precision Life
PAUL O'DONOHOE
Scientific Lead
ECOA & Mobile Health, Medidata Solutions
BOBBY KAURA
Seed Investment, EMEA Outreach
Illumina Accelerator
TONI DAY
Director of Quality & Regulatory Affairs
OrganOx
Véronique is a medical expert and
strategic thinker with over 30 years’
experience in the pharmaceutical,
biotech and digital health sectors.
She is a former Director at
AstraZeneca, where she was
responsible for global corporate
venturing activities, including the
creation and financing of the
company’s first spinout, Albireo
Pharma. She has an in-depth
understanding of what is required to
translate cutting edge science into
commercial reality.
Paul O’Donohoe is Scientific Lead,
ECOA and Mobile Health at Medidata
Solutions, a clinical software
platform provider. He is responsible
for developing the company's
scientific expertise for electronic
clinical outcome assessments and
mobile health in clinical trials, and
supports internal teams and
sponsors around the implementation
of industry and regulatory best
practices in studies using eCOA.
Bobby helped co-launch the
Cambridge Accelerator, a genomics
and VC backable company creation
engine. Previously, he was
responsible for heading commercial
market and business development
for Illumina EMEA with a focus on
how genomics can enable precision
health through the application of
next-generation sequencing
technologies. Prior to that he
worked in the NHS to deliver
sustainable transformation
programs.
Toni has over 20 years’ experience
in the design and development and
regulatory pathways for medical
devices and in vitro diagnostics. She
has worked for a number of start up
companies and joined OrganOx Ltd
in 2011, where she developed the
Quality Management System and
Regulatory Strategy for a complex
novel medical device. Gaining the CE
Mark in 2016. Toni has since led the
Organox FDA PMA program gaining
approval in 2021.
Véronique can advise on:
Routes to progress
translational research.
Identify spin-out
opportunities.
Paul O’Donohoe can advise on:
Development of fit for
purpose questionnaires for use
in clinical research.
Best practices for the
implementation of patient
questionnaires on electronic
systems.
Use of wearable devices and
sensors.
Bobby Kaura can advise on:
Strategy and Execution.
Market and Business
Development.
Leadership and Mentoring.
Pharma and Diagnostics
(personalised healthcare).
Toni can advise on
Regulatory strategies and
submissions.
Quality management systems.
Product classification.
Software as a medical device.
Medical device design,
development and lifecyle
compliance including clinical
trials.